Fungicidal composition containing oxadiazole compounds

A synergistic fungicidal composition comprising a mixture of component (1) and component (2), wherein component (1) is selected from the group consisting of:

• 2-(4-fluorophenoxy)-1-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)ethan-1-one (I-2);
• 2-((6-fluoropyridin-3-yl)oxy)-1-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)ethan-1-one (I-3);
• or
• 2-((4-fluorophenyl)amino)-1-(4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl)ethan-1-one (I-8);
• and
• and component (2) is at least one further active compound selected from the group consisting of):
• inhibitors of complex III at Qo site, selected from the group consisting of:
• azoxystrobin (A001), flufenoxystrobin (A007), fluoxastrobin (A008), kresoxim-methyl (A009), mandestrobin (A010), metominostrobin (A011), orysastrobin (A012), picoxystrobin (A013), pyraclostrobin (A014), pyraoxystrobin (A016), trifloxystrobin (A017), pyribencarb (A019), famoxadone (A021), fenamidone (A021a) and metyltetraprole (A025);
• inhibitors of complex III at Qi site, selected from the group consisting of:
• florylpicoxamid (A044) and metarylpicoxamid (A045);
• inhibitors of complex II, selected from the group consisting of benzovindiflupyr (A047), bixafen (A048), boscalid (A049), cyclobutrifluram (A051), fluopyram (A053), flubeneteram (A054), flufenoxadiazam (A055), flutolanil (A056), fluxapyroxad (A057), furametpyr (A058), fluindapyr (A059), isopyrazam (A060), isoflucypram (A062), inpyrfluxam (A063), pyrapropoyne (A066), penflufen (A067), penthiopyrad (A068), pydiflumetofen (A069), N-[2-(3,4-difluorophenyl)phenyl]-3-(trifluoromethyl)pyrazine-2-carboxamide (A070), sedaxane (A071), tecloftalam (A072), and thifluzamide (A073);
• other respiration inhibitors, selected from the group consisting of:
• flumetylsulforim (A093) and fluazinam (A097);
• C14 demethylase inhibitors, selected from the group consisting of:
• cyproconazole (B004), difenoconazole (B005), epoxiconazole (B008), fluoxytioconazole (B009), flutriafol (B013), hexaconazole (B014), propiconazole (B022), prothioconazole (B023), tebuconazole (B025), tetraconazole (B026), triticonazole (B029), mefentrifluconazole (B038), and triforine (B051);
• a delta14-reductase inhibitors selected from fenpropimorph (B056);
• inhibitors with multi site action, selected from the group consisting of:
• copper (H002), copper acetate (H003), copper hydroxide (H004), copper oxychloride (H005), basic copper sulfate (H006),
• mancozeb (H009), metiram (H012), propineb (H013),
• chlorothalonil (H018), folpet (H021), and dithianon (H036);
• and
• a melanin synthesis inhibitors selected from tricyclazole (I004).